David M. Weber - 07 Feb 2022 Form 4 Insider Report for ABIOMED INC

Role
Chief Operating Officer
Signature
/s/ Marc. A Began (by power of attorney)
Issuer symbol
N/A
Transactions as of
07 Feb 2022
Net transactions value
-$3,067,532
Form type
4
Filing time
09 Feb 2022, 16:43:27 UTC
Previous filing
05 Nov 2021
Next filing
18 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock, $.01 par value Options Exercise $6,465 +300 +0.23% $21.55 131,614 07 Feb 2022 Direct F4
transaction ABMD Common Stock, $.01 par value Sale $90,076 -300 -0.23% $300.25 131,314 07 Feb 2022 Direct F5, F6
transaction ABMD Common Stock, $.01 par value Options Exercise $159,750 +7,413 +5.6% $21.55 138,727 08 Feb 2022 Direct F4
transaction ABMD Common Stock, $.01 par value Sale $1,467,140 -4,884 -3.5% $300.40 133,843 08 Feb 2022 Direct F5, F7
transaction ABMD Common Stock, $.01 par value Sale $193,003 -641 -0.48% $301.10 133,202 08 Feb 2022 Direct F5, F8
transaction ABMD Common Stock, $.01 par value Sale $585,280 -1,888 -1.4% $310.00 131,314 08 Feb 2022 Direct F5, F9
transaction ABMD Common Stock, $.01 par value Options Exercise $67,064 +3,112 +2.4% $21.55 134,426 09 Feb 2022 Direct F4
transaction ABMD Common Stock, $.01 par value Sale $965,311 -3,112 -2.3% $310.19 131,314 09 Feb 2022 Direct F5, F10
holding ABMD Common Stock, $.01 par value 15,497 07 Feb 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABMD Stock Option (Right to Buy) Disposed to Issuer $0 -10,825 -100% $0.000000* 0 07 Feb 2022 Common Stock 0 $21.55 Direct F1, F2, F4
holding ABMD Stock Option (right to buy) 10,000 07 Feb 2022 Common Stock 0 $66.25 Direct F1, F2
holding ABMD Stock Option (right to buy) 7,000 07 Feb 2022 Common Stock 0 $99.62 Direct F2, F3
holding ABMD Stock Option (right to buy) 8,000 07 Feb 2022 Common Stock 0 $134.51 Direct F2, F3
holding ABMD Stock Option (right to buy) 6,500 07 Feb 2022 Common Stock 0 $381.97 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 6,000 07 Feb 2022 Common Stock 0 $266.39 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 5,000 07 Feb 2022 Common Stock 0 $223.90 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 4,969 07 Feb 2022 Common Stock 0 $283.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F3 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F4 Exercise of stock options pursuant to reporting owners 10b5-1 plan.
F5 Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F6 This price represents the sale price of the transactions on the reported date at $300.2533. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F7 This price represents the sale price of the transactions on the reported date at $300.3973. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8 This price represents the sale price of the transactions on the reported date at $301.0966. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F9 This price represents the sale price of the transactions on the reported date at $310.00. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F10 This price represents the sale price of the transactions on the reported date at $310.19. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.